Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Greg Brown

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Plos One|March 6, 2013
Levels of cholesterol in small LDL particles predict atherosclerosis progression and incident CHD in the HDL-Atherosclerosis Treatment Study (HATS)Paul T Williams, Xue-Qiao Zhao, Santica M Marcovina, et al.
Journal of the American College of Cardiology|April 19, 2008
Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemiaJohn R Guyton, B Greg Brown, Sergio Fazio, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|October 25, 2006
Reproducibility of carotid atherosclerotic lesion type characterization using high resolution multicontrast weighted cardiovascular magnetic resonanceBaocheng Chu, Binh An P Phan, Niranjan Balu, et al.
The American Journal of Cardiology|November 22, 2012
Effects of niacin on glucose levels, coronary stenosis progression, and clinical events in subjects with normal baseline glucose levels (<100 mg/dl): a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), HDL-Atherosclerosis Treatment Study (HATS), Armed Forces Regression Study (AFREGS), and Carotid Plaque Composition by MRI during lipid-lowering (CPC) studyBinh An P Phan, Luis Muñoz, Pey Shadzi, et al.
Atherosclerosis|March 8, 2014
Comparison of four methods of analysis of lipoprotein particle subfractions for their association with angiographic progression of coronary artery diseasePaul T Williams, Xue-Qiao Zhao, Santica M Marcovina, et al.
Atherosclerosis|April 13, 2005
Tracking atherosclerosis regression: a clinical tool in preventive cardiologyAllen Taylor, Leslee J Shaw, Zahi Fayad, et al.
Biochimica Et Biophysica Acta|October 12, 2005
Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular diseaseMarian C Cheung, B Greg Brown, Emily K Marino Larsen, et al.
Journal of Clinical Lipidology|September 20, 2014
Prolonged combination lipid therapy is associated with reduced carotid intima-media thickness: a case-control study of the 20-year Familial Atherosclerosis Treatment - Observational Study (FATS-OS)Binh An P Phan, Andrew B Moore, Joseph Davis, et al.
The American Journal of Cardiology|February 5, 2004
Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study)Xue-Qiao Zhao, Josh S Morse, Alice A Dowdy, et al.
The American Journal of Cardiology|November 26, 2009
Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS)Xue-Qiao Zhao, Richard A Krasuski, Jefferson Baer, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Plos One|March 6, 2013
Levels of cholesterol in small LDL particles predict atherosclerosis progression and incident CHD in the HDL-Atherosclerosis Treatment Study (HATS)Paul T Williams, Xue-Qiao Zhao, Santica M Marcovina, et al.
Journal of the American College of Cardiology|April 19, 2008
Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemiaJohn R Guyton, B Greg Brown, Sergio Fazio, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|October 25, 2006
Reproducibility of carotid atherosclerotic lesion type characterization using high resolution multicontrast weighted cardiovascular magnetic resonanceBaocheng Chu, Binh An P Phan, Niranjan Balu, et al.
The American Journal of Cardiology|November 22, 2012
Effects of niacin on glucose levels, coronary stenosis progression, and clinical events in subjects with normal baseline glucose levels (<100 mg/dl): a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), HDL-Atherosclerosis Treatment Study (HATS), Armed Forces Regression Study (AFREGS), and Carotid Plaque Composition by MRI during lipid-lowering (CPC) studyBinh An P Phan, Luis Muñoz, Pey Shadzi, et al.
Atherosclerosis|March 8, 2014
Comparison of four methods of analysis of lipoprotein particle subfractions for their association with angiographic progression of coronary artery diseasePaul T Williams, Xue-Qiao Zhao, Santica M Marcovina, et al.
Atherosclerosis|April 13, 2005
Tracking atherosclerosis regression: a clinical tool in preventive cardiologyAllen Taylor, Leslee J Shaw, Zahi Fayad, et al.
Biochimica Et Biophysica Acta|October 12, 2005
Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular diseaseMarian C Cheung, B Greg Brown, Emily K Marino Larsen, et al.
Journal of Clinical Lipidology|September 20, 2014
Prolonged combination lipid therapy is associated with reduced carotid intima-media thickness: a case-control study of the 20-year Familial Atherosclerosis Treatment - Observational Study (FATS-OS)Binh An P Phan, Andrew B Moore, Joseph Davis, et al.
The American Journal of Cardiology|February 5, 2004
Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study)Xue-Qiao Zhao, Josh S Morse, Alice A Dowdy, et al.
The American Journal of Cardiology|November 26, 2009
Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS)Xue-Qiao Zhao, Richard A Krasuski, Jefferson Baer, et al.
Pageof 3